[1]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.1329-1331
[2]Patent:WO2016/100162,2016,A2.Locationinpatent:Page/Pagecolumn34
[1]Patent:WO2016/100162,2016,A2
32968-44-8
35629-72-2
1060816-08-1 | 2-(tert-Butyl)oxazole-4-carboxylic acid | AA0092Q8 | MFCD11847678
1189107-54-7 | 7-Bromo-4-hydroxy-8-methylquinoline-3-carboxylic acid | AA0093FF | MFCD12674984
1135-01-9 | BenzenesulfonaMide, 4-propoxy- | AA0093RC | MFCD00460574
1015070-53-7 | Trans (+/-)-3-Amino-4-phenylpyrrolidine-1-carboxylic acid tert-butyl ester | AA00941U | MFCD03002045
1110656-38-6 | 2-Amino-5-(4-trifluoromethoxyphenyl)pyridine | AA00946Y | MFCD17496170
11113-62-5 | ENNIATIN FROM MICROBIAL SOURCE | AA0094B4 | MFCD00214209
1076-47-7 | 2,3,4-Trimethylbenzoic acid | AA0094OS | MFCD20638198
1060804-15-0 | 5-Cyanopyridine-3-sulfonyl chloride | AA00953T | MFCD13189095
1135283-57-6 | 5-Bromo-6-cyclopropyl-2-oxo-1,2-dihydropyridine-3-carbonitrile | AA0095I0 | MFCD11841020
1016713-62-4 | 1-(1,4-diazepan-1-yl)-2-(3-fluorophenyl)ethanone | AA0095TJ | MFCD09813907